Principal Investigator position in Cancer Immunology/Immunotherapy at the Institute for Research in Immunology and Cancer (IRIC) – Université de Montréal
The Institute for Research in Immunology and Cancer (IRIC) in partnership with the Faculty of Medicine of the Université de Montréal (UdeM) invites applications for a Principal Investigator position in the broad domain of Cancer Immunology/Immunotherapy. IRIC and UdeM are committed to developing world class expertise in this field. The new Principal Investigator will play a pivotal role in complementing the research strengths of the Institute.
Specifically, outstanding applications are sought in the areas of human or other mammalian models, antigen discovery, presentation and targeting, immune tolerance and immune checkpoints, pharmacogenomics, chimeric antigen receptors, biologics, small molecule-antibody conjugates, small molecules/immunotherapy combinations.
Applicants must hold a Ph.D. and/or M.D. degree, and have a strong publication record. Candidates will be expected to develop an innovative, internationally recognized, externally funded research program. IRIC - UdeM offers competitive recruitment packages commensurate with experience and qualifications, a research intensive environment, state-of-the art facilities and competitive graduate training programs. New Principal Investigator will be cross-appointed in a Department of the Faculty of Medicine of UdeM.
Applicants should submit a CV, a statement of research interests (including an outline for an independent research program), along with three letters of reference via the https://academicjobsonline.org/ajo/jobs/9704 website prior to November 7th, 2017. Applications will only be accepted in electronic (PDF) format. We thank all applicants for their interest, however only short listed candidates for the position, which could start as early as September 2018, will be contacted.
The primary objective of IRIC is to elucidate the molecular underpinnings of cancer and to devise innovative approaches to cure cancer. IRIC is located in a state-of-the-art new building on the main campus of UdeM. It currently hosts 28 Principal Investigators and over 450 trainees, graduate students, postdoctoral fellows, research associates and support staff. IRIC also comprises several cutting edge technological platforms. These include Bioimaging, Biophysics & NMR, Flow Cytometry, Genomics, High-Throughput Screening (chemical, RNAi and CRISPR), Histology, Medicinal Chemistry, Proteomics, and one of the largest animal facilities in Canada. A collegial and curiosity-driven research environment is a key characteristic of the Institute. For more information, please visit us at www.iric.ca.
About the Université de Montréal
The Université de Montréal is an international university in a city rated the World's Best Student City 2017 according to QS Top Universities (https://www.topuniversities.com/city-rankings/2017). UdeM is among the five leading research universities in Canada. Together with its two affiliated schools, HEC Montréal and École Polytechnique, it constitutes one of the largest centers of higher education in North America. For more information, please visit www.umontreal.ca.
The city of Montreal is renowned for its unique vibe, its authenticity, its great lifestyle, its many festivals and its large range of international events. Located at the cultural and geographic crossroads of Europe and North America, Montreal is a cosmopolitan city of 4 million that is open to the world. It is the second largest French speaking city in the world after Paris, yet more than half of the Montreal population is equally at ease in French and in English. A world leader in such industries as aeronautics, information technology and communications, life sciences and health technologies, the city is also recognized for innovations in multimedia, the arts and urban planning. For more information, please visit www.mtl.org/en.
The Université de Montréal application process allows all professors in a Department of interest to access all documents unless the applicant explicitly states in his / her cover letter that access to the application package should be limited to the selection committee. This restriction will be lifted if the applicant is invited for an interview.
Employment Equity Program
The Université de Montréal upholds the principles of employment equity and encourages applications from women, members of visible minorities, ethnic minorities, persons with disabilities and Aboriginal people.
In compliance with Canadian immigration requirements, priority shall be given to Canadian citizens and permanent residents.